Literature DB >> 27437260

Trabeculectomy with Mitomycin-C in Patients with Iridocorneal Endothelial Syndrome: A Case Series.

Vaibhav Kumar Jain1, Reena Sharma1, Sushil Ojha1, Anupama Tandon1, Meenu Babber1, Gunjan Jain1, Ifsa Sami1.   

Abstract

Iridocorneal Endothelial syndrome (ICE) is a rare ocular disorder characterized by abnormal endothelization of angle structure and iris producing characteristic manifestations including secondary angle closure glaucoma. We describe the clinical course of three patients with secondary glaucoma due to ICE syndrome who underwent trabeculectomy with mitomycin-C. At last follow-up, all patients had controlled IOP (<18 mm Hg) off drug. Early postoperative period was accompanied by shallowing of anterior chamber, diffuse vascularisation of bleb, frequent episodes of high IOP which were managed successfully. Trabeculectomy with MMC offers a good treatment choice for the management of secondary glaucoma associated with ICE syndrome.

Entities:  

Keywords:  ICE syndrome; Secondary glaucoma; Trabeculectomy with MMC

Year:  2016        PMID: 27437260      PMCID: PMC4948436          DOI: 10.7860/JCDR/2016/16506.7782

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  9 in total

1.  Primary trabeculectomy in young adults: long-term clinical results and factors influencing the outcome.

Authors:  P C Jacobi; T S Dietlein; G K Krieglstein
Journal:  Ophthalmic Surg Lasers       Date:  1999 Sep-Oct

2.  Surgical results in iridocorneal endothelial syndrome.

Authors:  M Kidd; J Hetherington; S Magee
Journal:  Arch Ophthalmol       Date:  1988-02

3.  The corneal endothelium and the spectrum of essential iris atrophy.

Authors:  D G Campbell; M B Shields; T R Smith
Journal:  Am J Ophthalmol       Date:  1978-09       Impact factor: 5.258

4.  Outcomes of Primary Trabeculectomy With Mitomycin-C in Glaucoma Secondary to Iridocorneal Endothelial Syndrome.

Authors:  Premanand Chandran; Harsha L Rao; Anil K Mandal; Nikhil S Choudhari; Chandra S Garudadri; Sirisha Senthil
Journal:  J Glaucoma       Date:  2016-07       Impact factor: 2.503

5.  Outcome of trabeculectomy with mitomycin-C in the iridocorneal endothelial syndrome.

Authors:  I M Lanzl; R P Wilson; D Dudley; J J Augsburger; I M Aslanides; G L Spaeth
Journal:  Ophthalmology       Date:  2000-02       Impact factor: 12.079

6.  Long-term surgical outcomes of patients with glaucoma secondary to the iridocorneal endothelial syndrome.

Authors:  E A Doe; D L Budenz; S J Gedde; N R Imami
Journal:  Ophthalmology       Date:  2001-10       Impact factor: 12.079

7.  Glaucoma and the iridocorneal endothelial syndrome.

Authors:  H C Laganowski; M G Kerr Muir; R A Hitchings
Journal:  Arch Ophthalmol       Date:  1992-03

8.  The essential iris atrophies.

Authors:  M B Shields; D G Campbell; R J Simmons
Journal:  Am J Ophthalmol       Date:  1978-06       Impact factor: 5.258

9.  Proliferative endotheliopathy with iris abnormalities. The iridocorneal endothelial syndrome.

Authors:  R C Eagle; R L Font; M Yanoff; B S Fine
Journal:  Arch Ophthalmol       Date:  1979-11
  9 in total
  1 in total

Review 1.  Iridocorneal endothelial syndrome: clinical perspectives.

Authors:  Andrew Walkden; Leon Au
Journal:  Clin Ophthalmol       Date:  2018-04-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.